Hepatobiliary tumor organoids for personalized medicine: a multicenter view on establishment, limitations, and future directions

Gilles S. van Tienderen, Ling Li, Laura Broutier, Yoshimasa Saito, Patricia Inacio, Meritxell Huch, Florin M. Selaru, Luc J.W. van der Laan, Monique M.A. Verstegen

研究成果: Comment/debate査読

3 被引用数 (Scopus)

抄録

Reliable establishment of tumor organoids is paramount to advance applications of organoid technology for personalized medicine. Here, we share our multi-center experience on initiation and tumorigenic confirmation of hepatobiliary cancer organoids. We discuss current concerns, propose potential solutions, and provide future perspectives for improvements in hepatobiliary cancer organoid establishment.

本文言語English
ページ(範囲)226-230
ページ数5
ジャーナルCancer Cell
40
3
DOI
出版ステータスPublished - 2022 3月 14

ASJC Scopus subject areas

  • 腫瘍学
  • 癌研究

フィンガープリント

「Hepatobiliary tumor organoids for personalized medicine: a multicenter view on establishment, limitations, and future directions」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル